These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 21152215
1. Herpes Zoster Infections in SLE in a University Hospital in Saudi Arabia: Risk Factors and Outcomes. Sayeeda A, Al Arfaj H, Khalil N, Al Arfaj AS. Autoimmune Dis; 2010 Sep 13; 2011():174891. PubMed ID: 21152215 [Abstract] [Full Text] [Related]
4. Prevalence and risk factors of herpes zoster infection in patients with biopsy proven lupus nephritis undergoing immunosuppressive therapies. Mok CC, Tse SM, Chan KL, Ho LY. Lupus; 2020 Jul 13; 29(8):836-844. PubMed ID: 32408851 [Abstract] [Full Text] [Related]
5. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. Kahl LE. J Rheumatol; 1994 Jan 13; 21(1):84-6. PubMed ID: 8151595 [Abstract] [Full Text] [Related]
6. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study. Hu SC, Yen FL, Wang TN, Lin YC, Lin CL, Chen GS. J Am Acad Dermatol; 2016 Jul 13; 75(1):49-58. PubMed ID: 26946984 [Abstract] [Full Text] [Related]
7. Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus. Hu SC, Lin CL, Lu YW, Chen GS, Yu HS, Wu CS, Lan CC. Acta Derm Venereol; 2013 May 13; 93(3):314-8. PubMed ID: 22983107 [Abstract] [Full Text] [Related]
8. Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy. Opastirakul S, Chartapisak W. Pediatr Nephrol; 2005 Dec 13; 20(12):1750-5. PubMed ID: 16133037 [Abstract] [Full Text] [Related]
10. Herpes zoster in patients with systemic lupus erythematosus. Moutsopoulos HM, Gallagher JD, Decker JL, Steinberg AD. Arthritis Rheum; 1978 Dec 13; 21(7):798-802. PubMed ID: 697950 [Abstract] [Full Text] [Related]
11. Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or noninflammatory musculoskeletal disorders. Pope JE, Krizova A, Ouimet JM, Goodwin JL, Lankin M. J Rheumatol; 2004 Feb 13; 31(2):274-9. PubMed ID: 14760796 [Abstract] [Full Text] [Related]
12. Herpes zoster vaccination in systemic lupus erythematosus: the current status. Mok CC. Hum Vaccin Immunother; 2019 Feb 13; 15(1):45-48. PubMed ID: 30130445 [Abstract] [Full Text] [Related]
13. Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis. Garnier C, Ribes D, Chauveau D, Huart A, Pugnet G, Adoue D, Prevot G, Alric L, Delobel P, Derumeaux H, Mengelle C, Sailler L, Moulis G. J Rheumatol; 2018 Nov 13; 45(11):1541-1548. PubMed ID: 30008461 [Abstract] [Full Text] [Related]
14. Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study. Ferreira JC, Marques HH, Ferriani MP, Gormezano NW, Terreri MT, Pereira RM, Magalhães CS, Campos LM, Bugni V, Okuda EM, Marini R, Pileggi GS, Barbosa CM, Bonfá E, Silva CA. Lupus; 2016 Jun 13; 25(7):754-9. PubMed ID: 26821966 [Abstract] [Full Text] [Related]
16. Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus. Borba EF, Ribeiro AC, Martin P, Costa LP, Guedes LK, Bonfá E. J Clin Rheumatol; 2010 Apr 13; 16(3):119-22. PubMed ID: 20216330 [Abstract] [Full Text] [Related]
17. Herpes zoster vaccination in SLE: a pilot study of immunogenicity. Guthridge JM, Cogman A, Merrill JT, Macwana S, Bean KM, Powe T, Roberts V, James JA, Chakravarty EF. J Rheumatol; 2013 Nov 13; 40(11):1875-80. PubMed ID: 24037550 [Abstract] [Full Text] [Related]
18. Fatal visceral disseminated varicella zoster infection during initial remission induction therapy in a patient with lupus nephritis and rheumatoid arthritis-possible association with mycophenolate mofetil and high-dose glucocorticoid therapy: a case report. Habuka M, Wada Y, Kurosawa Y, Yamamoto S, Tani Y, Ohashi R, Ajioka Y, Nakano M, Narita I. BMC Res Notes; 2018 Mar 05; 11(1):165. PubMed ID: 29506558 [Abstract] [Full Text] [Related]
19. Association Between Mycophenolate Mofetil Use and Subsequent Infections Among Hospitalized Patients with Systemic Lupus Erythematosus: A Nested Case-Control Study. Guo Q, Zhang X, Sun S, Tang X, Shen W, Liang J, Yao G, Geng L, Ding S, Chen H, Wang H, Hua B, Zhang H, Wang D, Feng X, Sun L, Jin Z. Rheumatol Ther; 2023 Dec 05; 10(6):1535-1554. PubMed ID: 37742321 [Abstract] [Full Text] [Related]
20. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zerón P, Bertolaccini L, Babini A, Moreno A, D'Cruz D, Khamashta MA. Medicine (Baltimore); 2008 Nov 05; 87(6):311-318. PubMed ID: 19011502 [Abstract] [Full Text] [Related] Page: [Next] [New Search]